Moderna, Inc. (MRNA)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $13.67 billion. The enterprise value is $4.86 billion.

Market Cap	13.67B
Enterprise Value	4.86B

Important Dates

The last earnings date was Friday, February 14, 2025, before market open.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Moderna has 384.82 million shares outstanding. The number of shares has increased by 0.52% in one year.

Current Share Class	384.82M
Shares Outstanding	384.82M
Shares Change (YoY)	+0.52%
Shares Change (QoQ)	-3.51%
Owned by Insiders (%)	9.59%
Owned by Institutions (%)	73.16%
Float	347.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.22
Forward PS	5.49
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.

Current Ratio	3.67
Quick Ratio	3.35
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.77% and return on invested capital (ROIC) is -18.46%.

Return on Equity (ROE)	-28.77%
Return on Assets (ROA)	-15.14%
Return on Invested Capital (ROIC)	-18.46%
Return on Capital Employed (ROCE)	-33.05%
Revenue Per Employee	$577,857
Profits Per Employee	-$635,893
Employee Count	5,600
Asset Turnover	0.20
Inventory Turnover	31.04

Taxes

Income Tax	-46.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.16% in the last 52 weeks. The beta is 1.59, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-59.16%
50-Day Moving Average	38.50
200-Day Moving Average	77.45
Relative Strength Index (RSI)	48.60
Average Volume (20 Days)	13,590,328

Short Selling Information

The latest short interest is 40.60 million, so 10.55% of the outstanding shares have been sold short.

Short Interest	40.60M
Short Previous Month	43.01M
Short % of Shares Out	10.55%
Short % of Float	11.68%
Short Ratio (days to cover)	3.29

Income Statement

In the last 12 months, Moderna had revenue of $3.24 billion and -$3.56 billion in losses. Loss per share was -$9.28.

Revenue	3.24B
Gross Profit	-2.77B
Operating Income	-3.95B
Pretax Income	-4.33B
Net Income	-3.56B
EBITDA	-3.76B
EBIT	-3.95B
Loss Per Share	-$9.28

Balance Sheet

The company has $7.03 billion in cash and $710.00 million in debt, giving a net cash position of $8.81 billion or $22.89 per share.

Cash & Cash Equivalents	7.03B
Total Debt	710.00M
Net Cash	8.81B
Net Cash Per Share	$22.89
Equity (Book Value)	10.90B
Book Value Per Share	28.31
Working Capital	5.89B

Cash Flow

In the last 12 months, operating cash flow was -$3.00 billion and capital expenditures -$1.05 billion, giving a free cash flow of -$4.06 billion.

Operating Cash Flow	-3.00B
Capital Expenditures	-1.05B
Free Cash Flow	-4.06B
FCF Per Share	-$10.54

Margins

Gross margin is -85.63%, with operating and profit margins of -121.91% and -110.04%.

Gross Margin	-85.63%
Operating Margin	-121.91%
Pretax Margin	-111.46%
Profit Margin	-110.04%
EBITDA Margin	-116.07%
EBIT Margin	-121.91%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.52%
Shareholder Yield	-0.52%
Earnings Yield	-26.04%
FCF Yield	-29.66%

Analyst Forecast

The average price target for Moderna is $59.65, which is 67.89% higher than the current price. The consensus rating is "Hold".

Price Target	$59.65
Price Target Difference	67.89%
Analyst Consensus	Hold
Analyst Count	20
Revenue Growth Forecast (5Y)	22.97%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.29 and a Piotroski F-Score of 2.

Altman Z-Score	7.29
Piotroski F-Score	2